BIORA THERAPEUTICS INC (PROG) Stock Analyst Earnings Estimates
NASDAQ:PROG - Nasdaq - US74319F1075 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 144M 12.50% | 74.3M -48.40% | 1.247M -98.32% | -100.00% | |||||
| EBITDA YoY % growth | -133.75M -23.69% | -190.14M -42.16% | -116.4M 38.78% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -140.1M -22.68% | -195.2M -39.33% | -117.837M 39.63% | N/A | N/A | N/A | N/A | N/A | |
| Operating Margin | -97.29% | -262.72% | -9,449.64% | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -2.23 64.98% | -0.50 77.59% | -0.50 | -0.52 -4.08% | -0.50 3.96% | -0.49 2.04% |
| Q1 / 22 | Q2 / 22 | Q3 / 22 | Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.13 77.23% | -0.12 81.17% | -0.11 76.72% | -0.13 76.32% | -0.09 28.00% | -0.07 41.67% | -0.05 52.38% | -0.05 61.54% |
| Revenue Q2Q % growth | -100.00% | -100.00% | -100.00% | -100.00% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2021 Q2Q % growth | -0.56 63.40% | -0.16 | -0.40 | -243.14% |
| Q3 2021 Q2Q % growth | -0.46 54.46% | -0.46 | 0.00 | -0.97% |
| Q2 2021 Q2Q % growth | -0.65 89.36% | -0.82 | 0.17 | 21.00% |
| Q1 2021 Q2Q % growth | -0.56 | -0.83 | 0.27 | 32.39% |
| Q4 2020 Q2Q % growth | -1.53 | -0.84 | -0.69 | -82.48% |
| Q3 2020 Q2Q % growth | -1.01 | -0.73 | -0.28 | -38.30% |
| Q2 2020 Q2Q % growth | -6.11 | -0.85 | -5.26 | -621.71% |
Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2021 Q2Q % growth | 435K -96.95% | 255K | 180K | 70.59% |
| Q3 2021 Q2Q % growth | 182K -99.30% | 3.876M | -3.694M | -95.30% |
| Q2 2021 Q2Q % growth | 463K -97.32% | 19.095M | -18.632M | -97.58% |
| Q1 2021 Q2Q % growth | 24.53M 45.75% | 25.909M | -1.379M | -5.32% |
| Q4 2020 Q2Q % growth | 14.28M | 25.218M | -10.938M | -43.37% |
| Q3 2020 Q2Q % growth | 25.94M | 35.439M | -9.499M | -26.80% |
| Q2 2020 Q2Q % growth | 17.27M | 26.712M | -9.442M | -35.35% |
| Q1 2020 Q2Q % growth | 16.83M -64.58% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |